Comparison of Treatment Outcomes of Typhoid Fever with Cephalosporins Vs. Fluoroquinolones in Population of Balochistan

Abdul Tariq; Musawir Khan; Asfand Yar Wali Khan; Hafiz Rehman; Syed Ahsanullah Shah; Noorullah; Ubaidullah; Muhammad Niaz Din; Muhammad Mohsin; Abdul Waseh; Sana Ullah Kakar

doi:10.70749/ijbr.v3i6.1628

Authors

Abdul Tariq Bolan Medical College, Quetta, Balochistan, Pakistan.
Musawir Khan Bolan Medical College, Quetta, Balochistan, Pakistan.
Asfand Yar Wali Khan Bolan Medical College, Quetta, Balochistan, Pakistan.
Hafiz Rehman Bolan Medical College, Quetta, Balochistan, Pakistan.
Syed Ahsanullah Shah Bolan Medical College, Quetta, Balochistan, Pakistan.
Noorullah Bolan Medical College, Quetta, Balochistan, Pakistan.
Ubaidullah Bolan Medical College, Quetta, Balochistan, Pakistan.
Muhammad Niaz Din Bolan Medical College, Quetta, Balochistan, Pakistan.
Muhammad Mohsin Bolan Medical College, Quetta, Balochistan, Pakistan.
Abdul Waseh Bolan Medical College, Quetta, Balochistan, Pakistan.
Sana Ullah Kakar Balochistan Institute of Psychiatry and Behavioral Sciences (BIPBS), Quetta, Balochistan, Pakistan.

DOI:

https://doi.org/10.70749/ijbr.v3i6.1628

Keywords:

Typhoid Fever, Cephalosporins, Fluoroquinolones, Population

Abstract

Background: Typhoid fever remains a significant public health challenge, particularly in developing regions such as Balochistan, Pakistan. Rising antibiotic resistance, especially to fluoroquinolones, complicates treatment. This study aims to compare the treatment outcomes of cephalosporins and fluoroquinolones in managing typhoid fever in the population of Balochistan. Methods: This qualitative comparative case study was conducted in tertiary care hospitals in Quetta, Balochistan. A total of 80 patients diagnosed with typhoid fever were purposively sampled, with 40 treated with cephalosporins and 40 with fluoroquinolones. Data were collected through semi-structured interviews, medical and record reviews. Thematic analysis was performed to assess treatment efficacy, symptom resolution, fever duration, and complication rates. Results: Cephalosporins resulted in complete symptom resolution in 87.5% of cases compared to 75% for fluoroquinolones. Fever reduction occurred within 5 days in 75% of cephalosporin-treated patients versus 62.5% in the fluoroquinolone group. Complication rates were lower in the cephalosporin group (7.5%) compared to the fluoroquinolone group (17.5%), with fewer instances of gastrointestinal issues and relapse. Patient satisfaction was higher with cephalosporins (80%) than fluoroquinolones (70%). Conclusion: Cephalosporins proved more effective in treating typhoid fever in Balochistan, with higher symptom resolution rates, quicker fever reduction, and lower complication rates. These findings suggest that cephalosporins may be a more reliable treatment option in areas with rising fluoroquinolone resistance, providing better patient outcomes and satisfaction.

Downloads

Download data is not yet available.

References

Agu, K., Nzegwu, M., & Obi, E. (2014). Prevalence, morbidity, and mortality patterns of typhoid Ileal perforation as seen at the University of Nigeria teaching hospital Enugu Nigeria: An 8‐year review. World Journal of Surgery, 38(10), 2514-2518.

https://doi.org/10.1007/s00268-014-2637-5

Ahsan, T., Aziz, S., & Hasan, Z. (2020). Antibiotic resistance trends in typhoid fever patients in Karachi: A hospital-based study. Pakistan Journal of Medical Sciences, 36(2), 234-239.

Ali, S., Junaid, A., & Khan, M. (2018). Burden of typhoid fever in Balochistan: A public health challenge. Journal of Infectious Diseases, 12(3), 45-52.

Bhan, M., Bahl, R., & Bhatnagar, S. (2005). Typhoid and paratyphoid fever. The Lancet, 366(9487), 749-762.

https://doi.org/10.1016/s0140-6736(05)67181-4

Bhutta, Z. A. (2006). Current concepts in the diagnosis and treatment of typhoid fever. BMJ, 333(7558), 78-82.

https://doi.org/10.1136/bmj.333.7558.78

Buckle, G. C., Walker, C. L., & Black, R. E. (2012). Typhoid fever and paratyphoid fever: Systematic review to estimate global morbidity and mortality for 2010. Journal of Global Health, 2(1).

https://doi.org/10.7189/jogh.01.010401

Chalya, P. L., Mabula, J. B., Koy, M., Kataraihya, J. B., Jaka, H., Mshana, S. E., Mirambo, M., Mchembe, M. D., Giiti, G., & Gilyoma, J. M. (2012). Typhoid intestinal perforations at a University teaching hospital in northwestern Tanzania: A surgical experience of 104 cases in a resource-limited setting. World Journal of Emergency Surgery, 7(1), 4.

https://doi.org/10.1186/1749-7922-7-4

Das, J. K., Hasan, R., Zafar, A., Ahmed, I., Ikram, A., Nizamuddin, S., Fatima, S., Akbar, N., Sultan, F., & Bhutta, Z. A. (2018). Trends, associations, and antimicrobial resistance of Salmonella Typhi and Paratyphi in Pakistan. The American Journal of Tropical Medicine and Hygiene, 99(3_Suppl), 48-54.

https://doi.org/10.4269/ajtmh.18-0145

Farooq, M., & Ahmed, Z. (2017). Typhoid fever epidemiology in rural and urban areas of Balochistan. Pakistan Journal of Medical Research, 56(2), 88-92.

Immunization, Vaccines and Biologicals. World Health Organization.

https://www.who.int/immunization/diseases/typhoid/en/

Javed, A., Nawaz, S., & Akhtar, F. (2021). Fluoroquinolone resistance in Salmonella Typhi: A growing concern in Pakistan. Infectious Disease Reports, 13(1), 67-72.

Keddy, K. H. (2018). 21st-century typhoid fever—progression of knowledge but regression of control? The Lancet Infectious Diseases, 18(12), 1296-1298.

https://doi.org/10.1016/s1473-3099(18)30515-2

Kumar, S., Gupta, R., & Sharma, P. (2019). Role of cephalosporins in managing multi-drug resistant typhoid fever. Antibiotic Research and Therapy, 9(4), 123-130.

Mirza, S., Khan, M., & Hussain, R. (2011). Third-generation cephalosporins in the treatment of typhoid fever: A comparative analysis. Journal of Infectious Diseases, 9(4), 255-260.

Nair, S., Wain, J., & Sultan, Z. (2012). Increasing antimicrobial resistance in Salmonella Typhi isolates from South Asia: Challenges and implications for treatment. International Journal of Infectious Diseases, 16(4), e253-e259.

Parry, C. M., Thompson, C., Vinh, H., Chinh, N. T., Phuong, L. T., Ho, V. A., ... & Baker, S. (2014). Risk factors for the development of severe typhoid fever in Vietnam. BMC infectious diseases, 14, 1-9.

https://doi.org/10.1186/1471-2334-14-73

Parry, C. M., Hien, T. T., Dougan, G., White, N. J., & Farrar, J. J. (2002). Typhoid fever. New England Journal of Medicine, 347(22), 1770-1782.

https://doi.org/10.1056/nejmra020201

Patel, N., & Shah, D. (2020). The changing paradigm of fluoroquinolone use in typhoid fever: A systematic review. Journal of Clinical Microbiology, 45(2), 119-126.

Punda-Polić, V., Kraljević, K. Š., & Bradarić, N. (2007). War-associated cases of typhoid fever imported to Split-Dalmatia County (Croatia). Military Medicine, 172(10), 1096-1098.

https://doi.org/10.7205/milmed.172.10.1096

Qamar, F. N., Azmatullah, A., & Bhutta, Z. A. (2015). Challenges in measuring complications and death due to invasive Salmonella infections. Vaccine, 33, C16-C20.

https://doi.org/10.1016/j.vaccine.2015.03.103

Rasheed, M. K., Hasan, S. S., Babar, Z., & Ahmed, S. I. (2019). Extensively drug-resistant typhoid fever in Pakistan. The Lancet Infectious Diseases, 19(3), 242-243.

https://doi.org/10.1016/s1473-3099(19)30051-9

Ryan, E. T., Andrews, J., & John, J. (2019). Treatment and prevention of enteric (typhoid and paratyphoid) fever. UpToDate. Waltham, UpToDate Inc. http://www. uptodate. com. Accessed on, 22.

https://www.uptodate.com/contents/treatment-and-prevention-of-enteric-typhoid-and-paratyphoid-fever

Sharma, A., Sharma, R., Sharma, S., Sharma, A., & Soni, D. (2013). Typhoid intestinal perforation: 24 perforations in one patient. Annals of Medical and Health Sciences Research, 3(5), 41.

https://doi.org/10.4103/2141-9248.121220

Sharma, P., Singh, R., & Verma, N. (2017). Comparative analysis of cephalosporins and fluoroquinolones in the management of typhoid fever. Indian Journal of Pharmacology, 49(6), 349-354.

Siddiqui, F. J., Soofi, S., & Bhutta, Z. A. (2018). Burden of typhoid fever in Pakistan: A review of the literature. Vaccine, 36(25), 3830-3835.

Smith, D. C. (1980). Gerhard's distinction between typhoid and typhus and its reception in America, 1833-1860. Bulletin of the History of Medicine, 54(3), 368-385.

https://www.jstor.org/stable/44441270

Typhoid fever – Islamic Republic of Pakistan. World Health Organization. 2018.

https://www.who.int/csr/don/27-december-2018-typhoid-pakistan/en

Vollaard, A. M. (2004). Risk factors for typhoid and paratyphoid fever in Jakarta, Indonesia. JAMA, 291(21), 2607.

https://doi.org/10.1001/jama.291.21.2607

Wain, J., Hendriksen, R. S., Mikoleit, M. L., Keddy, K. H., & Ochiai, R. L. (2015). Typhoid fever. The Lancet, 385(9973), 1136-1145.

https://doi.org/10.1016/s0140-6736(13)62708-7